โ Active Ingredient Overview Table:
| ๐ฌ Active Ingredient (Generic Name): | Mirtazapine |
|---|---|
| ๐ Indication: | Major Depressive Disorder (MDD), Off-Label: Anxiety, Insomnia |
| ๐บ๐ธ US Brand: | Remeron |
| ๐ญ Manufacturer: | Sun Pharmaceutical Industries Ltd. (Founded: 1993) |
| ๐ฆ Packaging: | 10 Tablets per Strip |
| ๐งช Strengths: | 15 mg, 30 mg |
| ๐ Delivery Time: | 6โ15 days |
๐ฟ What is Mirtazapine 15 mg & 30 mg (Mirtaz)?
Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) that antagonizes central presynaptic ฮฑ2-adrenergic inhibitory autoreceptors and heteroreceptors, enhancing norepinephrine and serotonin release. Additionally, it blocks 5-HT2 and 5-HT3 receptors and histamine H1 receptors, contributing to anxiolytic and sedative effects.
The 15 mg dose often serves as an initial therapy in MDD, providing balanced antidepressant efficacy with moderate sedationโbeneficial for patients with insomnia. Titrating to 30 mg can enhance mood-lifting effects while still offering tranquilizing benefits. Mirtazapineโs rapid onset and appetite stimulation profile make it suitable for depressed patients experiencing weight loss or poor sleep.
Clinical trials show significant improvement in Hamilton Depression Rating Scale scores by week two, with remission rates up to 40% at 30 mg. Off-label uses include reducing anxiety symptoms and improving sleep architecture without disrupting REM patterns.
For full prescribing details and safety data, consult the FDA label for Remeron, the Drugs.com monograph, and the NHS Medicines AโZ entry.
๐งฌ Pharmacology & Mechanism of Action
| Attribute | Detail |
|---|---|
| Chemical Formula | C17H19N3 |
| Molecular Weight | 265.36 g/mol |
| Bioavailability | ~50% |
| Metabolism | Hepatic (CYP1A2, CYP2D6, CYP3A4) |
| Half-Life | ~20โ40 hours |
Mirtazapineโs multi-receptor profile enhances mood and reduces anxiety while promoting sleep and appetite.
๐ก Indications & Dosing
| Condition | Dose & Administration |
|---|---|
| Major Depressive Disorder | Start 15 mg at bedtime; may increase to 30 mg after 1โ2 weeks based on response |
| Anxiety Disorders (Off-Label) | 15โ30 mg at bedtime |
| Insomnia (Off-Label) | 7.5โ15 mg at bedtime |
Take once daily at bedtime; do not split tablets. Titrate slowly to mitigate sedation and weight gain.
โ ๏ธ Warnings & Side Effects
Common:
- Somnolence, increased appetite
- Weight gain, dry mouth
- Dizziness, constipation
Serious:
- Neutropenia, agranulocytosis (rare)
- Serotonin syndrome (with other serotonergics)
- Orthostatic hypotension
Monitor blood counts periodically. Counsel on dietary changes for weight management and review concomitant serotonergic medications.
๐ฅ Storage Instructions
Store Mirtaz 15 mg & 30 mg at 20โ25ยฐC in original packaging. Protect from moisture and light.
๐ Availability & Purchasing
- USA: Prescription-only (Remeron); branded and generic forms.
- UK & EU: Prescription required; generic mirtazapine available.
- Australia: Prescription and TGA approval required.
International sourcing may lower costs; ensure regulatory compliance and valid prescription.
๐ Related Psychotropic Therapies
- Sertraline 50 mg โ SSRI antidepressant.
- Venlafaxine ER 75 mg โ SNRI.
- Bupropion SR 150 mg โ aminoketone antidepressant.
๐ฅ Educational Video on Mirtazapine
๐ฉโโ๏ธ Expert Insight: Dr. Ritu Verma, Psychiatrist
โMirtazapineโs dual impact on sleep and appetite, combined with rapid antidepressant effects, makes it a valuable option for patients with comorbid insomnia and underweight.โ








Reviews
There are no reviews yet.